About 374,000 people filed for their first week of unemployment benefits last week, the largest one-week rise since November 2012.
NEW YORK (CNNMoney) First-time claims for unemployment benefits suddenly jumped last week, marking the biggest one-week rise since Superstorm Sandy left thousands of people temporarily out of work.The rise was partly due to the government shutdown, as well as other temporary factors, the Department of Labor said.
About 374,000 people filed for their first week of unemployment benefits last week, 66,000 more than just a week earlier. It was the largest one-week rise since November 2012, when unemployment claims surged by 88,000 in the week following Superstorm Sandy.
Because initial unemployment claims closely correlate with layoffs, this report is considered one of the foremost economic indicators. But a series of recent temporary factors have muddled the numbers lately.
10 Best Solar Stocks To Watch Right Now: Virgin Australia Holdings Ltd (VBHLF)
Virgin Australia Holdings Limited (VAH) is an Australia-based company engaged in the development and operation of domestic and international airlines. VAH�� fleet includes ATR-72, Embraer 190, Boeing 737-700, Boeing 737-800, AIRBUS A330 and Boeing 777-300ER. It product includes Airbus A330 Business Class. During the fiscal year ended June 30, 2012, the Company carried 19,468,929 guests on 216 city pairs to 52 destinations, and operated 162,817 flights. On February 22, 2012, under the proposal, all of the shares in the international airline business of Virgin Australia were transferred to a new holding company, Virgin Australia International Holdings Pty Ltd. In April 2013, it acquired 100% of the issued share capital in Skywest Airlines Ltd. In July 2013, Virgin Australia Holdings Limited announced that it has acquired 60% interest of Tiger Airways Australia Pty Limited from Tiger Airways Holdings Limited. Advisors' Opinion:- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Australian stocks gave ground in early Friday trading, with banks broadly lower after overnight losses in the U.S., where investors worried that better-than-expected data would prompt the Federal Reserve to roll back stimulus soon. The S&P/ASX 200 (AU:XJO) lost 0.4% to 5,178.30, as National Australia Bank Ltd. (AU:NAB) (NAUBF) fell 1.8%, Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) lost 0.8%, and Macquarie Group Ltd. (AU:MQG) (MCQEF) retreated 1.3%. Among the resource shares, losses for gold both in New York and in early Asian electronic trade helped send Evolution Mining Ltd. (AU:EVN) (CAHPF) down 1.9% and Kingsgate Consolidated Ltd. (AU:KCN) (KSKGF) off 4.5%, though Newcrest Mining Ltd. (AU:NCM) (NCMGF) held the drop to 0.4%. Oil prices managed a modest gain, however, resulting in a 0.2% rise for Oil Search Ltd. (AU:OSH) (OISHF) and Karoon Gas Australia Ltd. (AU:KAR) (KRNGF) , while Woodside Petroleum Ltd. (AU:WPL)
10 Best Forestry Stocks For 2014: STMicroelectronics N.V.(STM)
STMicroelectronics N.V., an independent semiconductor company, engages in the design, development, manufacture, and marketing of a range of semiconductor integrated circuits and discrete devices. Its products include discrete and standard commodity components, application-specific integrated circuits, custom devices and semi-custom devices, and application-specific standard products for analog, digital, and mixed-signal applications. The company also offers subsystems and modules for the telecommunications, automotive, and industrial markets comprising mobile phone accessories, battery chargers, ISDN power supplies, and in-vehicle equipment for electronic toll payment, as well as provides Smartcard products. Its products are used in various microelectronic applications consisting of automotive products, computer peripherals, telecommunications systems, consumer products, industrial automation, and control systems. The company sells its products through distributors and ret ailers. STMicroelectronics N.V. was founded in 1987 and is headquartered in Geneva, Switzerland.
Advisors' Opinion:- [By Vanina Egea]
Reed Elsevier NV (ENL) is a diversified publisher and information provider. It works on a wide range of market segments that include scientific, technical and medical (STM); legal; risks solutions and business information and exhibitions. The key of the company�� growth, however, lies almost exclusively in two brands: Elsevier and LexisNexis.
- [By Michael Allison]
On Aug. 13, 2013, the company announced that shareholders of Energy Fuels overwhelmingly approved Energy Fuel's acquisition of Strathmore Minerals Corp. (STM). (See Energy Fuel's press release here.)
- [By Seth Jayson]
STMicroelectronics (NYSE: STM ) reported earnings on July 22. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 29 (Q2), STMicroelectronics met expectations on revenues and missed expectations on earnings per share.
10 Best Forestry Stocks For 2014: GrowLife Inc (PHOT)
GrowLife, Inc., formerly, Phototron Holdings, Inc., incorporated on March 7, 2001, sells and distributse mini-hydroponic greenhouses (Phototron Units) and horticultural seeds, mineral nutrient solutions, growing mediums and germination kits. On February 14, 2011, the Company entered into an agreement and plan of merger (Merger Agreement) with PHI Merger Corporation and its wholly owned subsidiary (MergerCo), and Phototron, Inc., (Phototron). On March 9, 2011, MergerCo was merged with and into Phototron and Phototron became its wholly owned subsidiary. In May 2011, it announced the launch of its wholly owned direct selling hydroponic gardening subsidiary, GrowLife Inc. In April 2012, it merged with SG Technologies Corp. A newly formed subsidiary of the Company was merged with and into SG Technologies Corp. On July 23, 2012, the Company acquired Greners.com, related to the online retail business operated by Greners.
The Company designs and manufactures indoor mini-hydroponic greenhouses capable of growing almost any herb, vegetable, flower, fruit or terrestrial plant better, stronger and faster than traditional farming methods. Its Phototron Units, consisting of 21 inch x 39 inch units and 21 inch x 51 inch units, provide between 18,900 and 36,000 lumens of light. Phototron Units also allow users to control what a plant receives, grow crops densely, avoid using pesticides, increase yields and automatically water plants.
The Company also formulates and sells horticultural seeds, mineral nutrient solutions, growing mediums and germination kits to facilitate hydroponic gardening through the use of its Phototron Units. In addition, it designs and manufactures replacement parts for its Phototron Units to facilitate customization of the units. It owns a mailing list and have a customer base exceeding 50,000 people. Its re-order program, which involves the sale of nutrients and related products and replacement parts for Phototron Units, represents 50% of its revenue.
Advisors' Opinion:- [By Bryan Murphy]
On Thursday of last week I was singing praises to Growlife Inc. (OTCBB:PHOT) for being able to put together such a strong management team. It already had a former Washington D.C.-based regulatory attorney in the fold as CEO (Sterling Scott), as well as a guy who brought a couple of key marijuana-related products to the market to serve as President of the company (the company president, Kyle Tracey, also happens to have a pretty thick industry-related rolodex). The big 'news' from PHOT then was the addition of Randy E. Breitman as the Director of Business Development. Breitman's background was as a real estate guy in the New Jersey/New York area, so he's been well-groomed to handle and close deals in what may be the toughest of market. Well, as at turns out, I could have waited three more days before explaining just how strong the PHOT management team was.
- [By Dan Burrows]
Medical Marijuana Inc. (MJNA) is up just under 100% so far this year and — get this — MJNA stock is actually the big-time laggard in the group. Next up comes Growlife (PHOT), as PHOT stock has gained “only” 150%. Indeed, when it comes to medical marijuana stock, anything less than a three-fold gain is small beer.
- [By Bryan Murphy]
The last few days have been nothing less than incredible for stocks like Cannabis Science Inc. (OTCMKTS:CBIS), Medbox Inc. (OTCMKTS:MDBX), Growlife Inc. (OTCBB:PHOT), and Medical Marijuana Inc. (OTCMKTS:MJNA). MJNA shares have jumped 90% since last Friday. PHOT is up 51% for the same timeframe. CBIS has grown 150%, while MDBX is up 112%. The reason? It's largely the legalization of recreational marijuana in Colorado - a law that went into effect as of January 1st. The legalization of medical marijuana in Illinois on the same day didn't hurt either. And truth be told, the event-based rally from the likes of Medbox and Cannabis Science makes basic sense - it's a landmark shift in the way this country views and treats marijuana. On the flipside, before wading any deeper into stocks like Medical Marijuana or Growlife, current and would-be owners might want to take a step back and look at the bigger picture.
- [By Bryan Murphy]
Though they've been lumped into the same category as Medical Marijuana Inc. (OTCMKTS:MJNA) and Tranzbyte Corp. (OTCMKTS:ERBB), names like Nuvilex Inc. (OTCMKTS:NVLX) and Growlife Inc. (OTCBB:PHOT) aren't actually marijuana stocks. Granted, PHOT and ERBB shareholders will benefit from the advent of legalized marijuana (and hemp) as much as shareholders of ERBB - a grower and dispenser - and MJNA shareholders will. But, in some way they're safer and more stable because they're not directly in the line of fire of potential regulation... or better-enforced regulation at the federal level. Indeed, there are several stocks that are circumventing the risk inherent with marijuana stocks, because they're not marijuana stocks at all. They are, in no particular order....
10 Best Forestry Stocks For 2014: Transcept Pharmaceuticals Inc.(TSPT)
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its principal product is the Intermezzo, a low dose sublingual formulation of zolpidem as a sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The company has a collaboration agreement with Purdue Pharmaceutical Products, L.P. for the commercialization of Intermezzo in the United States. It is also developing TO-2061, a low dose ondansetron adjunctive therapy, which is in Phase II study for patients with obsessive-compulsive disorder. The company was founded in 2002 and is based in Point Richmond, California.
Advisors' Opinion:- [By Roberto Pedone]
An under-$10 biotech stock that's trending very close to triggering a near-term breakout trade is Transcept Pharmaceuticals (TSPT), which is focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. This stock has been hit hard by the bears so far in 2013, with shares off by 36%.
If you take a look at the chart for TSPT, you'll notice that this stock has been trending sideways inside of a big consolidation pattern for the last three months, with shares moving between $2.71 on the downside and $3.25 on the upside. Shares of TSPT are counter-trending higher today in the face of a very weak tape. This move is starting to push the stock within range of triggering a near-term breakout trade above the upper-end of its sideways trading chart pattern.
Traders should now look for long-biased trades in TSPT if it manages to break out above its 50-day moving average at $2.91 a share and then once it takes out more near-term overhead resistance levels at $3.16 to $3.25 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 138,444 shares. If that breakout triggers soon, then TSPT will set up to re-test or possibly take out its next major overhead resistance levels at $4.23 to its 200-day at $4.39 a share. If those levels get taken out with volume, then TSPT could easily hit its next major overhead resistance levels at $5 to $5.50 a share.
Traders can look to buy TSPT off weakness to anticipate that breakout and simply use a stop that sits right below its recent low of $2.71 a share. One can also buy TSPT off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Roberto Pedone]
Transcept Pharmaceuticals (TSPT) is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. This stock closed up 6% to $2.98 in Thursday's trading session.
Thursday's Range: $2.81-$2.99
52-Week Range: $2.77-$6.77
Thursday's Volume: 138,000
Three-Month Average Volume: 158,095From a technical perspective, TSPT spiked sharply higher here right above some near-term support at $2.77 and back above its 50-day moving average at $2.95 with decent upside volume. This move is quickly pushing shares of TSPT within range of triggering a major breakout trade. That trade will hit if TSPT manages to take out some near-term overhead resistance levels at $3.16 to $3.25 with high volume. If that breakout hits, it would also push TSPT outside of a large consolidation pattern the stock has been in for the last three months.
Traders should now look for long-biased trades in TSPT as long as it's trending above some key near-term support at $2.77 and then once it sustains a move or close above those breakout levels with volume that hits near or above 158,095 shares. If that breakout triggers soon, then TSPT will set up to re-test or possibly take out its next major overhead resistance levels at $4.23 to its 200-day moving average at $4.50. Any high-volume move above those levels will then put $4.89 to $5 into range for shares of TSPT.
10 Best Forestry Stocks For 2014: Acadia Healthcare Company Inc (ACHC)
Acadia Healthcare Company, Inc., incorporated on October 24, 2005, is a provider of inpatient behavioral healthcare services in the United States. The Company's principal business is to develop and operate inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral health services in the United States. In January 2014, the Company announced that it has completed the acquisition of inpatient psychiatric facilities in Seattle, Washington, and Riverside, California.
In December 2011, the Company closed three outpatient facilities and a 24-bed substance abuse facility acquired from PHC on November 1, 2011. The Company's facilities and services consists of acute inpatient psychiatric facilities; residential treatment centers, group homes, therapeutic group homes and foster care; substance abuse centers; outpatient community-based services, and other behavioral services, including specialized educational services and call centers.
Acute Inpatient Psychiatric Facilities
The Company�� acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. The acute setting provides 24-hour observation, daily intervention and monitoring by psychiatrists. The Company's facilities, which offer acute care services provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses through a medical delivery that incorporates structured and intensive medical and behavioral therapies with 24-hour monitoring by a psychiatrist, psychiatric trained nurses, therapists and other direct care staff. As of December 31, 2011, the Company operated 10 facilities that provided acute care services in addition to other services.
Residential Treatment Centers/Group Homes
The Company�� residential treatment centers treat patients with behavioral disorders in a non-hospit! al setting. The facilities balance therapy activities with social, academic and other activities. The Company provides residential treatment care through a medical model residential treatment facility, which offers intensive, medically-driven interventions and individualized treatment regimens designed to deal with moderate to high level patient acuity. Treatment is provided by an interdisciplinary team coordinating psychopharmacological, individual, group and family therapy, along with specialized accredited educational programs in both secure and unlocked environments. As of December 31, 2011, the Company operated 14 facilities that provided residential treatment care, in addition to other services.
The Company's group home programs provide family-style living for youths in a single house or apartment within residential communities where supervision and support are provided by 24-hour staff. The Company also operates therapeutic group homes that provide treatment services for seriously, emotionally disturbed adolescents. The Company also manages therapeutic foster care programs, which are considered the least restrictive form of therapeutic placement for children and adolescents with emotional disorders. As of December 31, 2011, the Company operated three facilities that provided group home and therapeutic group home services.
Outpatient Community-Based Services
The Company's community-based services are provided for two age groups: children and adolescents (seven to 18 years of age) and young children (three months to six years of age). Community-based programs are designed to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric or chemical dependency disorder while enabling the youth to remain at home and within their community. Community-based programs developed for these age groups provide an array of therapeutic services to children. As of December 31, 2011, the Company operated eight facilities that! provided! community-based services.
Substance Abuse Centers
The Company�� Substance abuse centers (or SACs) provide a continuum of care for adults with addictive disorders and co-occurring mental disorders. The Company's detox, inpatient, partial hospitalization and outpatient treatment programs give patients access to the least restrictive level of care. As of December 31, 2011, the Company operated two SACs.
Specialized Education Services and Other Behavioral Services
The Company's education programs provide an educational experience to children and adolescents having special education needs. In some states, the Company provides educational services on an extended school year basis. The Company also has charter schools that utilize teaching methods that address therapeutic needs particular to learning and behavioral deficits of the students. The Company's education services also include vocational education and training that may allow those residents to become employable in entry level positions in the communities in, which they reside. GED preparation courses are also offered for students who require assistance in developing test-taking skills and who would benefit from tutoring services. As of December 31, 2011, the Company operated 11 facilities that provided educational services.
The Company also offers a variety of other behavioral health services for specialized populations who need specific treatment methods. Programs include at risk infant and children clinics, sexually maladaptive behavior (SMB) programs, programs for adolescent females, programs for the mentally retarded and developmentally disabled youth and programs for severe and persistently mentally ill youths.
Call Center Operations
The Company provides management , administrative and help lines services. The Company provides these servicesthrough contracts with railroads and a call center contract with Wayne County, Michigan.
The Company ! competes ! with UHS, Aurora Behavioral Health Care (Aurora) and Ascend Health Corporation (Ascend).
Advisors' Opinion:- [By Roberto Pedone]
Acadia Healthcare (ACHC) develops and operates a network of behavioral health facilities, providing premier psychiatric and chemical dependency services to its patients. This stock closed up 6.5% at $36.87 in Wednesday's trading session.
Wednesday's Volume: 792,000
Three-Month Average Volume: 360,986
Volume % Change: 124%From a technical perspective, ACHC soared higher here right above its 50-day moving average at $34.12 with strong upside volume. This move pushed shares of ACHC into breakout territory, since the stock took out its former 52-week high at $36. Shares of ACHC have been uptrending strong over the last six months, with shares soaring higher from its low of $24.93 to its intraday high of $37. During that move, shares of ACHC have been making mostly higher lows and higher highs, which is bullish technical price action.
Traders should now look for long-biased trades in ACHC as long as it's trending above its 50-day at $34.12 and then once it sustains a move or close above Wednesday's high of $37 with volume that's near or above 360,986 shares. If we get that move soon, then ACHC will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $40 to $45.
- [By Tom Lydon]
Top holdings based on the index include Acadia Healthcare Companies (ACHC), Amsurg Corporation (AMSG), Brookdale Senior Living (BKD), Clarcor (CLC) and Community Health Systems (CYH).
10 Best Forestry Stocks For 2014: Microsemi Corporation(MSCC)
Microsemi Corporation engages in the design, manufacture, and marketing of analog and mixed-signal integrated circuits (IC) and semiconductors primarily in the United States, Europe, and Asia. Its products include individual components and IC solutions that offer light, sound, and power management for desktop and mobile computing platforms, LCD TVs, and other power control applications. These products are used in notebook computers, data storage, wireless local area network, LCD backlighting, LCD TVs, LCD monitors, automobiles, telecommunications, test instruments, defense and aerospace equipment, sound reproduction, and data transfer equipment. The company?s semiconductor products include silicon rectifiers, zener diodes, low leakage and high voltage diodes, temperature compensated zener diodes, transistors, subminiature high power transient suppressor diodes, and pin diodes used in magnetic resonance imaging (MRI) machines. It also manufactures semiconductors for commer cial applications, such as automatic surge protectors, transient suppressor diodes used for telephone applications, and switching diodes used in computer systems. In addition, the company provides electronic components and systems for the defense and aerospace markets; multi-band radio frequency integrated circuit solutions; and anti-tamper solutions to defense clients in securing systems against tampering, piracy, and reverse engineering. It markets its products directly, as well as through electronic component distributors and independent sales representatives to the defense and security, aerospace, enterprise and communication, and industrial and alternative energy markets. The company was formerly known as Microsemiconductor Corporation and changed its name to Microsemi Corporation in February 1983. Microsemi Corporation was founded in 1960 and is headquartered in Aliso Viejo, California.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Microsemi (NASDAQ: MSCC) were down 4.18 percent to $23.16 after the company issued a downbeat Q1 outlook. - [By Lauren Pollock]
Microsemi Corp.(MSCC) agreed to pay almost $298 million to acquire Symmetricom Inc.(SYMM), a deal that will expand the power-management supplier’s exposure into the aerospace and defense industries while also immediately adding to earnings. Shares in Symmetricom soared.
10 Best Forestry Stocks For 2014: Geron Corporation (GERN)
Geron Corporation, a biopharmaceutical company, develops therapies for cancer. Its clinical development product candidates include Imetelstat, a telomerase inhibitor, which is in Phase II clinical trials for the treatment of metastatic breast cancer, advanced non-small cell lung cancer, thrombocythemia, and myeloma. The company was founded in 1990 and is based in Menlo Park, California.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the Move: Veeva Systems Inc. (NYSE: VEEV) is up a whopping 85.5% at $37.15 on huge demand following its IPO. Geron Corp. (NYSE: GERN) is up 39.7% at $4.37. Molycorp Inc. (NYSE: MCP) is down 1.8% at $5.48 following a secondary stock offering.
- [By Paul Ausick]
Stocks on the Move: Twitter Inc. (NYSE: TWIT) opened at $45.10, about 70% higher than its IPO price of $26, but posted only a small gain to close at $44.94, down 0.42%, after hitting $50.09 early in the day. Geron Corp. (NASDAQ: GERN) is up 44.8% at $5.21 following a good report on its myelofibrosis drug.
No comments:
Post a Comment